19
Jun
2024

Zhejiang Changming Pharmaceutical Co., Ltd.

Exhibitor at CPHI & PMEC China 2024 stand W2Q10b, Pharma Ingredients
About Us

Zhejiang Changming Pharmaceutical Co Ltd was established in 1998. Changming Pharm specializes in research, development, production and marketing of cardiovascular and other therapeutic drug related APls and intermediates. The leading products include: Enalapril, Ramipril, Lisinopril, Valsartan, Levetiracetam, etc. Changming Pharm has two manufacturing facilities in China, which located separately ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2024
  • 19 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand W2Q10b, Pharma Ingredients

Products Featured at CPHI & PMEC China 2024

  • (2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid

    Product (2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid

    Zhejiang changming pharmaceuticals co offers a wide range of products which includes (2s,3as,7as)-octahydro-1h-indole-2-carboxylic acid. It belongs to pharmaceutical intermediates category. Contact us for more information.
  • (2S,6R)-6-Amino-2-(2-thienyl)-1,4-thiazepan-5-one

    Product (2S,6R)-6-Amino-2-(2-thienyl)-1,4-thiazepan-5-one

    Zhejiang changming pharmaceuticals co offers a wide range of products which includes (2s,6r)-6-amino-2-(2-thienyl)-1,4-thiazepan-5-one. It belongs to pharmaceutical intermediates category. Contact us for more information.
  • (S,S,S)-2-Azabicyclo[3,3,0]-octane-carboxylic acid benzylester hydrochloride

    Product (S,S,S)-2-Azabicyclo[3,3,0]-octane-carboxylic acid benzylester hydrochloride

    Zhejiang changming pharmaceuticals co offers a wide range of products which includes (s,s,s)-2-azabicyclo[3,3,0]-octane-carboxylic acid benzylester hydrochloride. It belongs to pharmaceutical intermediates category. Contact us for more information.